Infectious Disease· Topic 7.17 Specific causative organisms· 7.17.17

Rubella

Rubella is a mild, droplet-spread togaviral illness in children and adults, notable mainly for its potential to cause severe congenital rubella syndrome when primary infection occurs in an unimmunized pregnant woman. Diagnosis is by rubella-specific IgM/IgG or polymerase chain reaction (PCR), treatment is supportive, and prevention is the measles-mumps-rubella (MMR) vaccine plus preconception immunity screening.

10 min read8 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Rubella ("German measles" or "3-day measles") is a mild, self-limited exanthematous illness in immunocompetent children and adults, caused by rubella virus, a togavirus, and spread by respiratory droplets.

  • Epidemiology

    Affects both children and young adults, unlike some exanthems concentrated in infancy.

  • Risk factors

    Lack of MMR vaccination or documented immunity is the dominant risk factor for acquiring rubella.

  • Pathophysiology

    Rubella virus is a single-stranded RNA togavirus that enters via the respiratory mucosa and replicates in respiratory epithelium and regional lymph nodes before viremic spread.

  • Clinical features

    In postnatal (acquired) rubella, a mild prodrome precedes the rash and is milder than the prodrome of measles: low-grade fever, malaise, and upper respiratory symptoms, in contrast to the higher…

  • Differential diagnosis

    Measles: a higher, more sustained fever with a toxic-appearing prodrome (cough, coryza, conjunctivitis), Koplik spots, and a confluent, cephalocaudally spreading rash that appears while the fever is…

  • Diagnosis

    Rubella is confirmed by rubella-specific IgM and IgG serology, which are the best initial tests, with detection of rubella virus RNA by polymerase chain reaction (PCR) serving as the most accurate…

  • Management

    First, for typical postnatal rubella in a child or nonpregnant adult, treatment is entirely supportive, since no antiviral therapy targets rubella virus; the priority is symptom control and isolation, not antimicrobial therapy.

  • Complications

    Congenital rubella syndrome is the most serious complication, occurring when primary maternal infection happens in a nonimmune pregnant woman; risk of fetal damage is roughly 40 to 60% when infection…

  • Prognosis

    Excellent for postnatal rubella in immunocompetent, nonpregnant individuals, with full recovery expected within about a week.

  • Prevention

    The two-dose live attenuated MMR vaccine is the cornerstone of prevention, with routine childhood timing at 12 to 15 months and 4 to 6 years; adults born in or after 1957 without documented immunity…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.